Expression profiling of the genes responding to zearalenone and its analogues using estrogen-responsive genes

FEBS Letters

Volumn 583, Issue 14, 2009, Pages 2377-2384

  Parveen, Meher ^a   Zhu, Yun ^a   Kiyama, Ryoiti ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Cell signaling; DNA microarray; Estrogen; Gene expression profile; Gene function

Indexed keywords

ALPHA ZEARALENOL; ALPHA ZERALANOL; BETA ZEARALENOL; BETA ZERALANOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYCOTOXIN; UNCLASSIFIED DRUG; ZEARALENONE; ZEARALENONE DERIVATIVE;

ARTICLE; CELL GROWTH; CELL STIMULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ESTROGEN ACTIVITY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ESTRADIOL; ESTROGENS; ESTROGENS, NON-STEROIDAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR STRUCTURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; ZEARALENONE;

EID: 67650163433     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.06.035     Document Type: Article

References (37)

1. Hidy P.H., Baldwin R.S., Greasham R.L., Keith C.L., and McMullen J. Zearalenone and some derivatives: production and biological activities. Adv. Appl. Microbiol. 22 (1977) 59-82
2. Tanaka T., Hasegawa A., Yamamoto S., Lee U.S., Sugiura Y., and Ueno Y. Worldwide contamination of cereals by the Fusarium mycotoxins, nivalenol, deoxynivalenol and zearalenone. 1. Survey of 19 countries. J. Agric. Food Chem. 36 (1988) 979-983
3. Diekman M.A., and Green M.L. Mycotoxins and reproduction in domestic livestock. J. Anim. Sci. 70 (1992) 1615-1627
4. Katzenellenbogen B.S., Katzenellenbogen J.A., and Mordecai D. Zearalenones: characterization of the estrogenic potencies and receptor interactions of a series of fungal beta-resorcylic acid lactones. Endocrinology 105 (1979) 33-40
5. Miksicek R.J. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49 (1994) 153-160
6. Creppy E.E. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol. Lett. 127 (2002) 19-28
7. Long G.G., and Diekman M.A. Effect of zearalenone on early pregnancy in guinea pigs. Am. J. Vet. Res. 50 (1989) 1220-1223
8. Osweiler G.D., Carson T.L., Buck W.B., and Van Gelder G.A. Biotoxins. Clinical, and Diagnostic Veterinary Toxicology. third ed. (1985), Kendall/Hunt Publishing Company, Dubuque, IA pp. 403-452
9. Bacha H., Chekir L., Ellouz F., Hadidane R., and Creppy E.E. Effects of zearalenone on fertilisation and gestation in rats. In: Scudamore K.A. (Ed). Proceedings of the UK Workshop, Occurrence and Significance of Mycotoxin (1993), The University of West London, Central Sciences Laboratory, London 258-262
10. Kim I.H., Son H.Y., Cho S.W., Ha C.S., and Kang B.H. Zearalenone induces male germ cell apoptosis in rats. Toxicol. Lett. 138 (2003) 185-192
11. Ouanes Z., Abid S., Ayed I., Anane R., Mobio T., Creppy E.E., and Bacha H. Induction of micronuclei by zearalenone in Vero monkey kidney cells and in bone marrow cells of mice: protective effect of vitamin E. Mutat. Res. 538 (2003) 63-70
12. IARC. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. In: IARC (Ed). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 56 (1993), IARC, Lyon, France 397-444
13. Pfohl-Leszkowicz A., Chekir-Ghedira L., and Bacha H. Genotoxicity of zearalenone, an oestrogenic mycotoxin: DNA adducts formation in female mouse tissues. Carcinogenesis 16 (1995) 2315-2320
14. Abid-Essefi S., Ouanes Z., Hassen W., Baudrimont I., Creppy E., and Bacha H. Cytotoxicity, inhibition of DNA and protein syntheses and oxidative damage in cultured cells exposed to zearalenone. Toxicol. In Vitro 18 (2004) 467-474
15. Yu Z., Zhang L., Wu D., and Liu F. Anti-apoptotic action of zearalenone in MCF-7 cells. Ecotoxicol. Environ. Saf. 62 (2005) 441-446
16. Moggs J.G., Ashby J., Tinwell H., Lim F.L., Moore D.J., Kimber I., and Orphanides G. The need to decide if all estrogens are intrinsically similar. Environ. Health Perspect. 112 (2004) 1137-1142
17. Buterin T., Koch C., and Naegeli H. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27 (2006) 1567-1578
18. Dip R., Lenz S., Antignac J.P., Le Bizec B., Gmuender H., and Naegeli H. Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Endocr. Relat. Cancer 15 (2008) 161-173
19. Inoue T. Toxicogenomics - a new paradigm of toxicology. In: Inoue T., and Pennie W.D. (Eds). Toxicogenomics (2003), Springer-Verlag, Tokyo, Japan pp. 213-218
20. Terasaka S., Aita Y., Inoue A., Hayashi S., Nishigaki M., Aoyagi K., Sasaki H., Wada-Kiyama Y., Sakuma Y., Akaba S., Tanaka J., Sone H., Yonemoto J., Tanji M., and Kiyama R. Expression profiling of the estrogen responsive genes for evaluation of estrogen activity among natural estrogens and industrial chemicals using a customized DNA microarray. Environ. Health Persp. 112 (2004) 773-781
21. Ise R., Han D., Takahashi Y., Terasaka S., Inoue A., Tanji M., and Kiyama R. Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett. 579 (2005) 1732-1740
22. Terasaka S., Inoue A., Tanji M., and Kiyama R. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol. Lett. 163 (2006) 130-141
23. Dong S., Inoue A., Zhu Y., Tanji M., and Kiyama R. Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of glycyrrhiza glabra root. Food Chem. Toxicol. 45 (2007) 2470-2478
24. Parveen M., Inoue A., Ise R., Tanji M., and Kiyama R. Evaluation of estrogenic activity of phthalate esters by gene expression profiling using a focused microarray (EstrArray). Environ. Toxicol. Chem. 27 (2008) 1416-1425
25. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., and Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82 (1990) 1107-1112
26. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998 95 (1998) 14863-14868
27. Edgar R., Domrachev M., and Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30 (2002) 207-210
28. Greco S., Storelli C., and Marsigliante S. Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin. J. Endocrinol. 188 (2006) 79-89
29. Shier W.T., Shier A.C., Xie W., and Mirocha C.J. Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 39 (2001) 1435-1438
30. Minervini F., Giannoccaro A., Cavallini A., and Visconti A. Investigation on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicol. Lett. 159 (2005) 272-283
31. Butt A.J., Dickson K.A., McDougall F., and Baxter R.C. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J. Biol. Chem. 278 (2003) 29676-29685
32. Liu, H., Du, J., Hu, C., Qi, H., Wang, X., Wang, S., Liu, Q. and Li, Z. (2009) Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells. J. Nutr. Biochem. (in press).
33. Lau W.S., Chen W.F., Chan R.Y., Guo D.A., and Wong M.S. Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells. Br. J. Pharmacol. 156 (2009) 1136-1146
34. Razandi M., Pedram A., Merchenthaler I., Greene G.L., and Levin E.R. Plasma membrane estrogen receptors exist and functions as dimers. Mol. Endocrinol. 18 (2004) 2854-2865
35. Pedram A., Razandi M., and Levin E.R. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20 (2006) 1996-2009
36. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
37. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632